Material properties in complement activation SM Moghimi, AJ Andersen, D Ahmadvand, PP Wibroe, TL Andresen, ... Advanced drug delivery reviews 63 (12), 1000-1007, 2011 | 279 | 2011 |
An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome PP Wibroe, D Ahmadvand, MA Oghabian, A Yaghmur, SM Moghimi Journal of Controlled Release 221, 1-8, 2016 | 192 | 2016 |
Complement activation cascade triggered by PEG–PL engineered nanomedicines and carbon nanotubes: The challenges ahead SM Moghimi, AJ Andersen, SH Hashemi, B Lettiero, D Ahmadvand, ... Journal of controlled release 146 (2), 175-181, 2010 | 190 | 2010 |
Nanobody; an old concept and new vehicle for immunotargeting F Rahbarizadeh, D Ahmadvand, Z Sharifzadeh Immunological investigations 40 (3), 299-338, 2011 | 126 | 2011 |
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled from a phage display peptide LP Wu, D Ahmadvand, J Su, A Hall, X Tan, ZS Farhangrazi, SM Moghimi Nature communications 10 (1), 4635, 2019 | 113 | 2019 |
T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: towards tumor-directed oligoclonal T cell therapy FR Jamnani, F Rahbarizadeh, MA Shokrgozar, F Mahboudi, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1840 (1), 378-386, 2014 | 99 | 2014 |
Genetically engineered T cells bearing chimeric nanoconstructed receptors harboring TAG-72-specific camelid single domain antibodies as targeting agents Z Sharifzadeh, F Rahbarizadeh, MA Shokrgozar, D Ahmadvand, ... Cancer letters 334 (2), 237-244, 2013 | 82 | 2013 |
Particulate systems for targeting of macrophages: basic and therapeutic concepts SM Moghimi, L Parhamifar, D Ahmadvand, PP Wibroe, TL Andresen, ... Journal of innate immunity 4 (5-6), 509-528, 2012 | 81 | 2012 |
Combined MUC1-specific nanobody-tagged PEG-polyethylenimine polyplex targeting and transcriptional targeting of tBid transgene for directed killing of MUC1 over-expressing … E Sadeqzadeh, F Rahbarizadeh, D Ahmadvand, MJ Rasaee, ... Journal of controlled release 156 (1), 85-91, 2011 | 77 | 2011 |
Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells FR Jamnani, F Rahbarizadeh, MA Shokrgozar, D Ahmadvand, ... Experimental cell research 318 (10), 1112-1124, 2012 | 65 | 2012 |
Anti-MUC1 nanobody can redirect T-body cytotoxic effector function SHA Bakhtiari, F Rahbarizadeh, S Hasannia, D Ahmadvand, FJ Iri-Sofla, ... Hybridoma 28 (2), 85-92, 2009 | 56 | 2009 |
Cell selection and characterization of a novel human endothelial cell specific nanobody D Ahmadvand, MJ Rasaee, F Rahbarizadeh, RE Kontermann, ... Molecular immunology 46 (8-9), 1814-1823, 2009 | 53 | 2009 |
Nanobody-based chimeric receptor gene integration in Jurkat cells mediated by PhiC31 integrase FJ Iri-Sofla, F Rahbarizadeh, D Ahmadvand, MJ Rasaee Experimental cell research 317 (18), 2630-2641, 2011 | 49 | 2011 |
A caspase 8-based suicide switch induces apoptosis in nanobody-directed chimeric receptor expressing T cells S Khaleghi, F Rahbarizadeh, D Ahmadvand, MJ Rasaee, P Pognonec International journal of hematology 95, 434-444, 2012 | 47 | 2012 |
Microfluidic platform for the continuous production and characterization of multilamellar vesicles: A synchrotron small-angle X-ray scattering (SAXS) study A Ghazal, M Gontsarik, JP Kutter, JP Lafleur, D Ahmadvand, A Labrador, ... The journal of physical chemistry letters 8 (1), 73-79, 2017 | 46 | 2017 |
A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment Z Farajpour, F Rahbarizadeh, B Kazemi, D Ahmadvand Biochemical and biophysical research communications 446 (1), 132-136, 2014 | 46 | 2014 |
The bactericidal effect of lysostaphin coupled with liposomal vancomycin as a dual combating system applied directly on methicillin-resistant Staphylococcus aureus infected … F Hajiahmadi, MY Alikhani, H Shariatifar, MR Arabestani, D Ahmadvand International journal of nanomedicine, 5943-5955, 2019 | 42 | 2019 |
Development of gold-coated magnetic nanoparticles as a potential MRI contrast agent AR Montazerabadi, MA Oghabian, R Irajirad, S Muhammadnejad, ... Nano 10 (04), 1550048, 2015 | 39 | 2015 |
CAR T-cell bioengineering: single variable domain of heavy chain antibody targeted CARs F Rahbarizadeh, D Ahmadvand, SM Moghimi Advanced Drug Delivery Reviews 141, 41-46, 2019 | 36 | 2019 |
ImmunoPEGliposome-mediated reduction of blood and brain amyloid levels in a mouse model of Alzheimer's disease is restricted to aged animals L Ordóñez-Gutiérrez, A Posado-Fernández, D Ahmadvand, B Lettiero, ... Biomaterials 112, 141-152, 2017 | 36 | 2017 |